New cyclodextrin bioconjugates for active tumour targeting

Author： Salmaso Stefano   Bersani Sara   Semenzato Alessandra   Caliceti Paolo  

Publisher： Informa Healthcare

ISSN： 1061-186X

Source： Journal of Drug Targeting, Vol.15, Iss.6, 2007-07, pp. : 379-390

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Passive and Active Tumour Targeting with Nanocarriers

By  

Current Drug Discovery Technologies, Vol. 8, Iss. 3, 2011-09 ,pp. : 188-196

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting integrins for the control of tumour angiogenesis

By Akalu Abebe   Cretu Alexandra   Brooks Peter C  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 12, 2005-12 ,pp. : 1475-1486

Informa Healthcare

Access to resources Recommend Favorite

Tumour Targeting with Systemically Administered Bacteria

By  

Current Gene Therapy, Vol. 10, Iss. 1, 2010-02 ,pp. : 3-14

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticle- and Liposome-carried Drugs: New Strategies for Active Targeting and Drug Delivery Across Blood-brain Barrier

By  

Current Drug Metabolism, Vol. 14, Iss. 6, 2013-07 ,pp. : 625-640

Bentham Science Publishers

Access to resources Recommend Favorite

Tumour targeting by microtubule-depolymerising vascular disrupting agents

By Kanthou Chryso   Tozer Gillian M  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 11, 2007-11 ,pp. : 1443-1457

Informa Healthcare

Access to resources Recommend Favorite